Research reveals how dormant breast cancer cells survive in bone marrow and evade therapy for years CHINA, June 4, 2026 ...
Growing momentum for RAS inhibition at ASCO highlights Namodenoson’s RAS pathway inhibition and encouraging data in ...
Cellular phase separation may play a previously underappreciated role in regulating kinase activity, offering therapeutic ...
A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...
"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.
Our body receives and processes a vast number of signals. Chemical signals serve as guidance cues and ensure, for example, ...
An AI-assisted drug discovery platform using transfer learning has identified a promising gp130 inhibitor for colorectal ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are ...
Morning Overview on MSN
Daraxonrasib, a daily RAS-blocking pill, raised pancreatic cancer survival from 6.7 to 13.2 months with fewer severe side effects than chemo
Patients with metastatic pancreatic cancer who had already failed at least one round of chemotherapy lived roughly twice as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results